Enzo Biochem (ENZ) Issued U.S. Patent for Treatment of Liver Cancer Using Ozanimod
Go back to Enzo Biochem (ENZ) Issued U.S. Patent for Treatment of Liver Cancer Using Ozanimod| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| ENZO BIOCHEM, Inc. (NYSE: ENZ) | Delayed: 1.06 -0.03 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $7.00 | |||
| Open | $1.10 | 52 Week Low | $4.00 | |||
| Day High | $1.10 | P/E | N/A | |||
| Day Low | $1.05 | EPS | $-0.43 | |||
| Volume | 77,130 | |||||
